Page last updated: 2024-10-25

clomipramine and Myelopathy

clomipramine has been researched along with Myelopathy in 1 studies

Clomipramine: A tricyclic antidepressant similar to IMIPRAMINE that selectively inhibits the uptake of serotonin in the brain. It is readily absorbed from the gastrointestinal tract and demethylated in the liver to form its primary active metabolite, desmethylclomipramine.
clomipramine : A dibenzoazepine that is 10,11-dihydro-5H-dibenzo[b,f]azepine which is substituted by chlorine at position 3 and in which the hydrogen attached to the nitrogen is replaced by a 3-(dimethylamino)propyl group. One of the more sedating tricyclic antidepressants, it is used as the hydrochloride salt for the treatment of depression as well as obsessive-compulsive disorder and phobias.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nygren, LG1
Fuxe, K1
Jonsson, G1
Olson, L1

Other Studies

1 other study available for clomipramine and Myelopathy

ArticleYear
Functional regeneration of 5-hydroxytryptamine nerve terminals in the rat spinal cord following 5, 6-dihydroxytryptamine induced degeneration.
    Brain research, 1974, Oct-04, Volume: 78, Issue:3

    Topics: Amines; Animals; Clomipramine; Hindlimb; Histocytochemistry; Male; Microscopy, Fluorescence; Nerve E

1974